ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms of Neurodegeneration and Neuroprotection for Retinal and Optic Nerve Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 68

Special Issue Editor


E-Mail Website
Guest Editor
Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan
Interests: neuroprotection; neuroprotective therapy; diabetic retinopathy; optic nerve
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Neuronal cell death is an irreversible change and associated with the pathogenesis of all retinal and optic nerve diseases. Because neuronal cell death is directly related to vision loss, neuronal cell death must be protected before the point of no return. A variety of types of cell death, such as necrosis, apoptosis, pyroptosis, autophagic cell death, ferroptosis, or necroptosis, can be associated with the pathogenesis of retinal and optic nerve diseases. Thus, multiple neuroprotective therapies against various types of cell death may be required for retinal and optic nerve diseases. To establish neuroprotective therapies, the precise mechanism of neuronal cell death must be elucidated. Otherwise, we cannot identify where the point of no return is.

This Special Issue focuses on the molecular mechanisms of neuronal cell death as well as neuroprotective and regenerative therapies for retinal and optic nerve diseases. This Special Issue covers all studies from bench to bed, and thus clinical studies and trials for neuroprotective therapies are also welcome. We hope that this Special Issue contributes to the development of medical science more than a little.

Prof. Dr. Toshiyuki Oshitari
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuroprotection
  • neurodegeneration
  • neuronal cell death
  • regeneration
  • cell death and survival pathways
  • neurovascular unit
  • oxidative stress
  • inflammation
  • advanced glycation end products
  • ischemia
  • optic nerve injuries
  • glaucoma
  • optic neuritis
  • retinitis pigmentosa
  • diabetic retinopathy
  • age-related macular degeneration
  • retinal vein/artery occlusion
  • gene therapy
  • cell plantation
  • nutrients
  • neuroprotectants
  • drug delivery
  • translational research

Published Papers

This special issue is now open for submission.
Back to TopTop